GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 209 filers reported holding GENMAB A/S in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $549,000 | -10.1% | 16,897 | 0.0% | 0.13% | +9.2% |
| Q1 2022 | $611,000 | -8.5% | 16,897 | 0.0% | 0.12% | -3.2% |
| Q4 2021 | $668,000 | -9.5% | 16,897 | 0.0% | 0.12% | -17.9% |
| Q3 2021 | $738,000 | +7.0% | 16,897 | 0.0% | 0.15% | +7.1% |
| Q2 2021 | $690,000 | -21.9% | 16,897 | -37.2% | 0.14% | -28.8% |
| Q1 2021 | $883,000 | +56.3% | 26,897 | +93.5% | 0.20% | +50.0% |
| Q4 2020 | $565,000 | +11.0% | 13,897 | 0.0% | 0.13% | 0.0% |
| Q3 2020 | $509,000 | +8.1% | 13,897 | 0.0% | 0.13% | -4.3% |
| Q2 2020 | $471,000 | +60.2% | 13,897 | 0.0% | 0.14% | +8.7% |
| Q1 2020 | $294,000 | -39.9% | 13,897 | -36.5% | 0.13% | -1.6% |
| Q4 2019 | $489,000 | -10.3% | 21,897 | -18.6% | 0.13% | -17.3% |
| Q3 2019 | $545,000 | – | 26,897 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |